| Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response AEH Elia, AP Boardman, DC Wang, EL Huttlin, RA Everley, N Dephoure, ... Molecular cell 59 (5), 867-881, 2015 | 387 | 2015 |
| Identification of racial inequities in access to specialized inpatient heart failure care at an academic medical center LA Eberly, A Richterman, AG Beckett, B Wispelwey, RH Marsh, ... Circulation: Heart Failure 12 (11), e006214, 2019 | 171 | 2019 |
| RFWD3-dependent ubiquitination of RPA regulates repair at stalled replication forks AEH Elia, DC Wang, NA Willis, AP Boardman, I Hajdu, RO Adeyemi, ... Molecular cell 60 (2), 280-293, 2015 | 154 | 2015 |
| A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation MS Davids, HT Kim, C Costello, AF Herrera, FL Locke, RO Maegawa, ... Blood, The Journal of the American Society of Hematology 135 (24), 2182-2191, 2020 | 78 | 2020 |
| CAR T‐cell therapy in large B cell lymphoma AP Boardman, G Salles Hematological oncology 41, 112-118, 2023 | 35 | 2023 |
| IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model BD Ng, A Rajagopalan, AI Kousa, JS Fischman, S Chen, A Massa, ... Blood 144 (2), 171-186, 2024 | 5 | 2024 |
| CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas GY Cederquist, J Schefflein, SM Devlin, GL Shah, R Shouval, ... Blood Advances 8 (19), 5192-5199, 2024 | 4 | 2024 |
| Infectious Complications in Patients with Relapsed or Refractory (R/R) Non-Hodgkin's Lymphoma (NHL) Treated with the Anti-CD20xCD3 Bispecific Antibody (BsAb) Mosunetuzumab Z Shahid, M Okwali, A Joseph, SK Seo, JK Lue, AP Boardman, P Caron, ... Blood 142, 4403, 2023 | 3 | 2023 |
| Impact of early histological transformation on survival in patients with follicular lymphoma E Luttwak, A Qiu, M Okwali, A Rivas-Delgado, I Isgor, AP Boardman, ... Blood 142 (Supplement 1), 3023-3023, 2023 | 3 | 2023 |
| Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: a prospective geriatric assessment (GA) study P Torka, E Drill, N Ganesan, M Oliveros, AP Boardman, P Caron, ... Blood 142, 70, 2023 | 2 | 2023 |
| Predictors and Implications of Renal Injury in Large Cell Lymphoma Patients Receiving CD19 CAR T Cell Therapy AP Boardman, V Gutgarts, JR Flynn, SM Devlin, A Alarcon Tomas, ... Blood 140 (Supplement 1), 4671-4672, 2022 | 2 | 2022 |
| Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes YK Valtis, S Devlin, R Shouval, K Rejeski, M Corona, A Luna De Abia, ... Blood Advances 9 (1), 151-161, 2025 | 1 | 2025 |
| Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors SE James, S Chen, BD Ng, JS Fischman, L Jahn, AP Boardman, ... Nature Biomedical Engineering, 1-23, 2024 | 1 | 2024 |
| Does BTKi improve CAR T-cell therapy in MCL? AP Boardman, ML Palomba Blood 143 (8), 653-655, 2024 | 1 | 2024 |
| Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience JK Lue, E Luttwak, P Caron, AP Boardman, KA David, A Rivas-Delgado, ... Blood 142, 3129, 2023 | 1 | 2023 |
| CCR1-targeting CAR T cells for acute myeloid leukemia S Chen, AP Boardman, SE James, MRM van den Brink Blood 142, 4808, 2023 | 1 | 2023 |
| Leucine zipper-based sorting system enables generation of multi-functional CAR T cells SE James, S Chen, BD Ng, JS Fischman, L Jahn, AP Boardman, ... bioRxiv, 2023.09. 13.557232, 2023 | 1 | 2023 |
| Targeting CD47 in lymphoid malignancies with CAR T cells. AP Boardman, S James, MRM Van Den Brink Journal of Clinical Oncology 41 (16_suppl), 2513-2513, 2023 | 1 | 2023 |
| Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy AP Boardman, V Gutgarts, J Flynn, SM Devlin, A Goldman, AA Tomas, ... Haematologica, 2020 | 1 | 2020 |
| RNA-Sequencing Reveals Direct Targets of Tumor Suppressor miR-203 in Human Mammary Epithelial Cells AP Boardman, VE Pedanou, TM Simone, MR Green | 1 | 2017 |